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ABSTRACT
The POU domain transcription factor OCT4 is a key regu-
lator of pluripotency in the early mammalian embryo and is
highly expressed in the inner cell mass of the blastocyst.
Consistent with its essential role in maintaining pluripo-
tency, Oct4 expression is rapidly downregulated during for-
mation of the trophoblast lineage. To enhance our under-
standing of the molecular basis of this differentiation event
in humans, we used a functional genomics approach involv-
ing RNA interference-mediated suppression of OCT4 func-
tion in a human ESC line and analysis of the resulting
transcriptional profiles to identify OCT4-dependent genes in
human cells. We detected altered expression of >1,000
genes, including targets regulated directly by OCT4 either
positively (NANOG, SOX2, REX1, LEFTB, LEFTA/EBAF
DPPA4, THY1, and TDGF1) or negatively (CDX2, EOMES,
BMP4, TBX18, Brachyury [T], DKK1, HLX1, GATA6, ID2,
and DLX5), as well as targets for the OCT4-associated stem
cell regulators SOX2 and NANOG. Our data set includes
regulators of ACTIVIN, BMP, fibroblast growth factor, and
WNT signaling. These pathways are implicated in regulat-
ing human ESC differentiation and therefore further vali-
date the results of our analysis. In addition, we identified a
number of differentially expressed genes that are involved in
epigenetics, chromatin remodeling, apoptosis, and metabo-
lism that may point to underlying molecular mechanisms
that regulate pluripotency and trophoblast differentiation in
humans. Significant concordance between this data set and
previous comparisons between inner cell mass and trophec-
toderm in human embryos indicates that the study of human
ESC differentiation in vitro represents a useful model of
early embryonic differentiation in humans. STEM CELLS
2007;25:500–510
INTRODUCTION
The earliest differentiation event in the mammalian embryo
occurs during formation of the blastocyst, when trophoblast
cells delaminate away from a residual cluster of undifferentiated
cells, the inner cell mass, containing the pluripotent embryonic
founder cells [1]. Little is known about regulation at this stage
of development in humans because of the ethical considerations
associated with experimental use of this scarce tissue. However,
with the establishment of pluripotent embryonic cell lines from
human blastocysts, it is now possible to consider investigating
molecular mechanisms that regulate the first stages in human
development in vitro [2, 3].
The POU domain transcription factor Oct4/OCT4 is a crit-
ical regulator of pluripotency in the mammalian embryo and is
expressed in unfertilized oocytes, the ICM and epiblasts of
pregastrulation embryos, and in primordial germ cells [4–6].
Downregulation of OCT4 expression during trophoblast differ-
entiation and the conversion of mutant embryos lacking Oct4
into exclusively trophoblast-like cells indicates that the tran-
scription factor is required to either establish or maintain pluri-
potency in the embryo [7]. Suppression of Oct4/OCT4 in ESCs
also induces trophoblast-like differentiation, confirming its es-
sential role in maintaining pluripotency and leading to the
proposal that an early function of this transcription factor is as
a “gatekeeper,” preventing differentiation along the trophoblast
lineage [8–10]. Studies in mouse and human cells indicate that
OCT4 is a component of a network of transcription factors,
including the homeobox protein NANOG and HMG-box tran-
scription factor SOX2, that cooperatively maintain pluripotency
in ESCs [8, 11–15]. In addition, ESCs also require inputs from
extrinsic factors to suppress differentiation. However, the ap-
parently distinct growth factor requirements of mouse and hu-
man embryonic stem (ES) [16–18] point to likely variations in
how these signals connect to the basic conserved transcriptional
regulatory circuits controlling differentiation of pluripotent stem
cells [19].
As an extension to our previous work [9, 20], we modeled
the first differentiation event in human embryos in vitro by
acutely depleting OCT4 from human ESCs using RNA interfer-
ence (RNAi)-mediated gene knockdown and examined the re-
sulting changes in global gene expression. Transcriptional
changes induced by OCT4 knockdown are expected to include
direct targets of the transcription factor, indirectly associated
genes linked with pluripotency, and genes activated upon dif-
ferentiation along the trophoblast lineage. Combining this in-
formation with other data sets on core transcriptional regulatory
networks controlling pluripotency and trophoblast differentia-
tion [14, 20] should provide additional insights into the molec-
Correspondence: James Adjaye, Ph.D., Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Ihnestrasse 73,
D-14195 Berlin, Germany. Telephone: 0049-30-8413-1203; Fax: 0049-30-8413-1128; e-mail: adjaye@molgen.mpg.de Received July 12,
2006; accepted for publication October 18, 2006; first published online in STEM CELLS EXPRESS October 26, 2006. ©AlphaMed Press
1066-5099/2007/$30.00/0 doi: 10.1634/stemcells.2006-0426

















ular events that underlie the earliest differentiation event in the
human embryo.
MATERIALS AND METHODS
Clone Selection and Microarray Fabrication
The selection of the 15,529 cDNA clones and fabrication of the
arrays was as previously described [20].
Cell Culture
Human ESCs (H1 clone) were grown under feeder-free conditions
as previously described [9]. Cells were adjusted to dissociation with
0.5 mM EDTA in phosphate-buffered saline (PBS), applied to the
cells at 37°C for 5–10 minutes, and routinely passaged in this way.
Cells were seeded 24 hours before transfections. For microarray
analysis, small interfering RNA (siRNA) transfections were carried
out in 75-cm2 flasks in triplicate for each siRNA duplex. Cells were
seeded at approximately 5  106 cells per flask for analysis at 24
hours after siRNA transfection or approximately 2  106 cells per
flask for analysis at 72 hours after siRNA transfection. For immu-
nohistochemistry, transfections were carried out in six-well plates,
and cells were seeded at 2  105 cells per well.
Transfections with siRNA
siRNA duplexes were obtained from Dharmacon RNA Technolo-
gies (Lafayette, CO, http://www.dharmacon.com) and reconstituted
following the manufacturer’s guidelines. Sense strand sequences for
the siRNA duplexes were as follows: enhanced green fluorescent
protein (EGFP), AAG AAC GGC AUC AAG GUG AAC;
OCT4–1, AAG GAU GUG GUC CGA GUG UGG; and OCT4-2,
Dharmacon siGENOME duplex 1 (D-019591-05-0010).
Triplicate ESC cultures were transfected individually with 80
nM siRNA duplexes using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA, http://www.invitrogen.com) lipofection reagent prepared
in OptiMEM (Invitrogen) following the manufacturer’s instructions.
The siRNA/Lipofectamine 2000 complex was added to the cells in
the appropriate volume of ESC culture medium. Cells were fed with
fresh culture medium 1 hour prior to transfection and following the
removal of the transfection reagent. Cells were transfected once
only for RNAi analysis after 24 hours. For RNAi analysis at 72
hours, cells were transfected twice; the second transfection was
carried out 24 hours after the first transfection.
Immunoblotting
Cells were lysed and sonicated in 1% SDS buffer. Lysates were
electrophoresed on 10% SDS-polyacrylamide gel electrophoresis
gels and immunoblotted as described previously [9]. SHP-2 (1:
1,000; sc-280; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
http://www.scbt.com), OCT4 (1:1,000; sc-5279; Santa Cruz Bio-
technology), SOX2 (1:1,000; sc-17320 X; Santa Cruz Biotechnol-
ogy), NANOG (1:250; 1997; R&D Systems Inc., Minneapolis,
http://www.rndsystems.com), and glyceraldehyde-3-phosphate
dehydrogenase (1:5,000; 4300; Ambion, Austin, TX, http://www.
ambion.com) antibodies were used. Secondary horseradish peroxi-
dase-conjugated antibodies (Amersham Biosciences, Buckingham-
shire, U.K., http://www.amersham.com) were used at a 1:5,000
dilution and detected with the enhanced chemiluminescence reagent
(Amersham Biosciences).
Immunohistochemistry
Cells were fixed with 100% methanol at 20°C for 10 minutes,
washed once in PBS, and permeabilized in 100% ethanol at room
temperature for 1 minute. Thereafter, the cells were washed twice in
PBS and blocked in PBS containing 10% goat serum (Sigma-
Aldrich, St. Louis, http://www.sigmaaldrich.com) for 1 hour at
room temperature. Primary antibodies for OCT4 (sc-5279) and
cytokeratin-18 (sc-6259) were purchased from Santa Cruz Biotech-
nology and used at 1:100 dilutions in PBS containing 1% goat
serum. Alexa Fluor 568 anti-mouse IgG (Invitrogen) secondary
antibody was used at a dilution of 1:400 to detect antibody binding.
Coverslips were mounted in Mowial (Calbiochem, San Diego,
http://www.calbiochem.com) solution with antifade supplemented
with 4,6-diamidino-2-phenylindole nuclear stain. All light and flu-
orescence microscopy was carried out using a Nikon Microphot SA
(Tokyo, http://www.nikon.com) microscope and camera.
RNA Isolation and In Vitro Transcription
Total RNA was isolated using TRIzol reagent (Invitrogen) treated
with DNase 1 (Promega GmbH, Mannheim, Germany, http://www.
promega.com). Messenger RNA amplifications were carried out
using the MegaScript T7 High Yield Transcription kit (Ambion)
using 3 g of total RNA as template. The purity, integrity, and
concentrations of generated amplified RNA were evaluated using
the Nanodrop Bioanalyzer (Nanodrop Technologies, Wilmington,
DE, http://www.nanodrop.com/).
Direct Labeling of RNA and Hybridizations
MIAME (Minimum Information About Microarray Experiments)
guidelines were adhered to in our experimental design. Three inde-
pendent labeling (dye swaps, Cy3, and Cy5) reactions per antisense
RNA sample pertaining to each biological replicate were carried out
using 3 g of aRNA per reaction. Full details of labeling and
hybridization reactions, slide washing, and scanning have been
described previously [20].
Global Data Analysis
Data were normalized in two steps. The first step accounted for the
dye effects caused by the difference in Cy3/Cy5 fluorescence la-
beling in each experimental sample. Here we used the LOWESS
method [21]. For each cDNA, we performed statistical tests based
on the replicate signals in experiments with EGFP- and OCT4-
depleted samples. Three standard tests were used in parallel, Stu-
dent’s t test, the Welch test, and Wilcoxon’s rank-sum test [22]. A
full description of the normalization process is detailed in the
supplemental online Materials and Methods.
Pathway Analysis
Array data were used to test whether entire groups of genes asso-
ciated with specific pathways show differential expression. Path-
ways were taken from the Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) database (version KEGG2, 01.06.2005, http://www.
genome.ad.jp/kegg/). The procedure has been described previously
[20].
Real-Time Reverse Transcription-Polymerase Chain
Reaction Analysis
Confirmations were carried out on a set of genes using RNA derived
from the two independent OCT4 siRNA transfections. The list of
primers used, annealing temperatures, genes under investigation,
and experimental details are shown in supplemental online Table 5
and supplemental online Materials and Methods.
Identification of Conserved Downstream Targets of
OCT4 in Mouse and Human ESCs
Genes differentially expressed 72 hours after OCT4 knockdown
were selected from the raw microarray data set on the basis of four
independent statistical tests (p value cutoff, .05) yielding sets of
approximately 1,104 up- and downregulated genes. HUGO gene
symbol IDs for these genes were checked for occurrence in the
OCT4-specific target lists generated by Boyer et al. [14] and Loh et
al. [15]. The complete lists of direct and indirect targets are given in
supplemental online Tables 6 and 7.
Online Database
To enable a global overview of altered gene expression at 24 and 72
hours post-transfection that can be interrogated, we have presented
the expression data as a database for searching for expression levels
of specific genes and their related gene ontologies (http://goblet.
molgen.mpg.de/cgi-bin/stemcell/pluripotency.cgi). We used gene on-

















tology terminology taken from the Gene Ontology website (http://
www.geneontology.org). This was imported into the SQLite
database (http://www.sqlite.org). Data analysis was carried out us-
ing R statistics software (http://www.r-project.org).
RESULTS
Depletion of OCT4 in Human Embryonic Stem H1
Cells Using siRNA Transfection
To identify factors associated with early stages in human ESC
and trophoblast differentiation, we have combined RNAi and
microarray based expression profiling to analyze global changes
in gene expression induced by suppression of OCT4 function.
Triplicate H1 ESC cultures were transfected with either OCT4
or control EGFP siRNA oligonucleotides, and RNA samples
were collected at 24 hours, when the very earliest changes in cell
morphology resulting from Oct4 knockdown are first apparent,
and at 72 hours, when the appearance of enlarged nuclei and
flattening of cells predominates within the cultures (Fig. 1A, 1C,
1D). These morphological changes were accompanied by a
reduction in the level of the protein as determined by Western
blotting (Fig. 1B) and immunocytochemistry (Fig. 1C). In line
with previous experiments, OCT4 siRNAs reduced OCT4 pro-
tein levels to less than 30% of the EGFP siRNA controls,
consistent with transfection efficiency of more than 70% [9].
OCT4 knockdown was also accompanied by a marked increase
in expression of the trophectoderm marker cytokeratin 18 and
incorporation of the protein into 10-nm filamentous structures
typical of an epithelial cell type (Fig. 1D) [20, 23].
Global Expression Analysis
For each of three transfections harvested at 24 and 72 hours,
triplicate RNA samples were labeled with either Cy3 or Cy5,
including dye swap. Transcription profiles were then generated
by using a cDNA microarray (Ensembl Chip) consisting of
15,529 resequenced and annotated clones. The overall correla-
tions between the OCT4 and EGFP RNAi expression data were
0.993 (24 hours) and 0.943 (72 hours), indicating that the
expression levels of the vast majority of genes remain unaltered
by the procedures. To judge whether a gene is expressed in the
respective cells, we computed a background (BG) tag for its
signal. This number reflects the proportion of background signal
lower than the actual signal [20]. Typically, a BG tag of 0.9
indicates detectable probe signals (Fig. 2B, bottom panel). Us-
ing this criterion, we found that 1,038 (6.63%) of genes repre-
sented on the chip (probes) were expressed solely at the 24-hour
stage, whereas 518 (3.31%) were expressed exclusively at the
72-hour stage, consistent with a restriction of gene expression
and therefore developmental competence upon stem cell differ-
entiation [24]. The vast majority of genes were either expressed
at both time points (5,923 genes; 37.83%) or not expressed at all
(8,178 genes; 52.23%). The full lists of genes expressed solely
at 24 and 72 hours after transfection and also at both time points,
together with the corresponding ratios, are presented in supple-
mental online Tables 1, 2, and 3, respectively. For a global
overview of the transcriptional changes resulting from the loss
of OCT4 function and insights into the physiological state of
human ESCs (hESCs) resulting from OCT4 depletion, we com-
bined the expression data at the 24- and 72-hour time points in
an online database for interrogating the expression levels of
specific genes and their related gene ontologies (http://goblet.
molgen.mpg.de/cgi-bin/stemcell/pluripotency.cgi).
To identify genes with altered expression levels as a result
of OCT4 knockdown, we compared the 24- and 72-hour repli-
cates, with EGFP knockdown at the same time points using
statistical tests for differential expression (described in Materi-
als and Methods). Three distinct tests (Student’s t test, the
Welch test, and Wilcoxon’s rank sum test) were used to mini-
mize individual bias [22]. By adopting this approach, we iden-
tified a subset of 1,104 marker genes from the 72-hour time
point. Of these marker genes, 399 (36%) were downregulated,
and another 705 were upregulated. Both sets of marker genes
were at a significance level of .05. For example, among these
differentially regulated marker genes are previously character-
ized downstream targets of OCT4, such as the pluripotency
markers NANOG and SOX2 and markers of undifferentiated
stem cells ZFP42, LEFTY1, LEFTY2, DPPA4, THY1,
FLJ10884, and TDGF1. The negatively regulated genes in-
cluded EOMES, BMP4, fibroblast growth factor 8 (FGF8),
Figure 1. Downregulation of OCT4 mRNA and protein in H1 human
ESCs (hESCs) by small interfering RNA (siRNA) transfection. (A):
Morphology of hESCs 72 hours after transfection with EGFP, OCT4
(1), and OCT4 (2) siRNA. (B): Western blot analysis of OCT4 protein
levels in siRNA-transfected ESCs. Cell lysates prepared 72 hours from
duplicate siRNA transfections were fractionated by SDS-polyacryl-
amide gel electrophoresis, immunoblotted, and probed with OCT4 and
SHP-2 (control) antibodies. The reduction in OCT4 protein in OCT4 (1)
and OCT4 (2) transfections was approximately 30% of the control
EGFP transfection. (C): OCT4 expression in siRNA-transfected cells.
Cells were fixed 72 hours after transfection, immunostained for OCT4,
and counterstained with 4,6-diamidino-2-phenylindole (DAPI). (D): Cy-
tokeratin 18 expression in siRNA-transfected hESCs. Cells were fixed
72 hours after transfection, immunostained for cytokeratin 18, and
counterstained with DAPI. Abbreviation: EGFP, enhanced green fluo-
rescent protein.
















DKK1, HLX1, GATA2, GATA6, ID2, and DLX5, which are
implicated in differentiation processes [14, 15], as well as a
large number of novel genes. These differentially regulated
genes are listed in supplemental online Table 4. Furthermore,
we computed Q values for each of the genes to assess statistical
significance by the false discovery rate (FDR) [25]. Using an
FDR level of 0.05 identifies 721 of the more than 1,104 genes
as significant. However, it should be stressed that FDR assess-
ment can also increase the false-negative rate. For example, ID2,
a differentiation marker directly regulated by OCT4 (supple-
mental online Table 6; Fig. 3) and verified as significant by p
value computation, was rejected by FDR assessment. At an FDR
level of 0.1, all genes were marked significant.
By comparing gene expression profiles from 24- and 72-
hour-post-transfection samples, we selected genes that show
changes in expression similar to those of the selected key genes
OCT4, EOMES, and BMP4. The OCT4 hierarchical cluster is
shown in Figure 2C and includes genes already implicated in the
maintenance of pluripotency and self-renewal, such as NANOG;
markers of undifferentiated stem cells LEFTY1, LEFTY2,
DPPA4, and THY1; and novel genes.
To have an overview of negatively regulated downstream
targets of OCT4, we repeated the profile analysis for EOMES
and BMP4, respectively (supplemental online Figs. 1 and 2).
EOMES encodes a T-box containing transcription factor ex-
pressed in the trophectoderm of human and mouse blastocyst
and has been shown to be required for mouse trophoblast
development and mesoderm formation [20, 26, 27]. The gene
encoding bone morphogenetic protein 4 (BMP4) is also highly
expressed in the human trophectoderm [20] and has been shown
to promote human embryonic stem cell differentiation into
trophoblast [17]. The critical trophoblast stem cell regulator
Figure 2. Global data analysis. (A): Effect of LOWESS normalization. Plotted are the ratios of the red and green signals for each spot (log scale,
y-axis) and the signal range (log scale, x-axis) of a typical experiment. Whereas the raw data show a nonlinear bias in particular at the extremes of
the signal area (top graph), after LOWESS normalization, this bias was eliminated (bottom graph). (B): Venn diagram of genes expressed at the
different time points of OCT4 knockdown. Gene expression was judged by a numerical value (BG tag) computed from a negative control sample
(bottom panel). (C): Cluster of genes that show expression patterns most similar to that of OCT4 across the experimental conditions. Colors
correspond to normalized signals. For each gene, signals were divided by the average gene signal across all conditions (log scale). Red boxes indicate
that the signal in the particular condition is higher than the average signal, whereas green boxes indicate the opposite. Hierarchical clustering was
performed on 199 genes that showed high variation across the four conditions and a significant difference in the OCT4 and EGFP RNAis using
Pearson correlation as a pairwise similarity measure and average linkage as an update rule. The analysis was done using J-Express Pro 2.6 software
(MolMine AS, Bergen, Norway http://www.molmine.com). Abbreviations: BG, background; EGFP, enhanced green fluorescent protein; hrs, hours;
RNAi, RNA interference.

















CDX2 could not be been included in this analysis because the
clone is not represented on our array. Nonetheless, real-time
polymerase chain reaction (PCR) analysis showed that its ex-
pression is induced upon depletion of OCT4 (Fig. 3).
Included in this set are genes implicated in ESC differenti-
ation, such as (a) the transcription factors ID3, TBX18, GATA6,
and HLX1 [14]; (b) signal transduction pathways crucial for the
maintenance of pluripotency, such as WNT (DKK1, FRZB,
FZD2), transforming growth factor  (TGF) (TGFB2), and
FGF (FGF8); and (c) cytoskeletal and extracellular matrix-
associated genes, such as MFAP5, COL4A1, KRT14, LOXL4,
and CLDN4, which encodes a tight junction protein crucial for
trophectoderm formation. These changes in gene expression
overlap with those identified in BMP4-treated hESCs [17] and
may reflect the morphological changes seen upon differentiation
of hESCs per se and adoption of trophoblast fate (Fig. 1A, 1D).
Expression patterns of a selection of the differentially ex-
pressed genes were verified independently using real-time PCR
and Western blotting of samples prepared from cells transfected
with either of two different OCT4 siRNAs (Fig. 3). The results
shown in Figure 3A confirmed the downregulation of key plu-
ripotency-controlling genes, OCT4, SOX2, and NANOG, and
ES-associated genes LEFTY1, LEFTY2, TDGF1, DNMT3B, and
ZFP42.
Expression of mesodermal (T/Brachyury) and ectodermal
(PAX6) markers was also downregulated, re-emphasizing the
lineage-restricted differentiation of OCT4-depleted cells. The
induction of CDX2 is in agreement with results obtained in
mouse and human ESCs [8, 10], but it differs from our previous
results with hESCs grown in mouse embryonic fibroblast
(MEF)-conditioned medium, presumably reflecting the im-
proved sensitivity of the current reverse transcription (RT)-PCR
assays and inherent variability in MEF-conditioned medium
preparations [9]. Confirmation of gene expression characteristic
of trophoblast lineage is supported by the upregulated expres-
sion of key markers, such as EOMES, CDX2, and BMP4 [9, 10,
17, 20]. The list of primer sequences used for this assay is given
in supplemental online Table 5. Western blot analysis (Fig. 3B)
shows downregulation of the transcription factors NANOG and
SOX2 proteins upon OCT4 knockdown, consistent with their
cooperation with OCT4 as part of an interdependent core hES
transcriptional regulatory circuit [14, 15].
Downstream Targets of OCT4
Our experimental approach will identify both direct and indirect
targets downstream of OCT4. To distinguish between these
possibilities, we cross-checked the OCT4-regulated genes with
the recently compiled set of transcription targets for OCT4,
SOX2, and NANOG identified in hESCs using chromatin im-
munoprecipitation (ChIP) coupled to promoter microarrays and
ChIP-pair end diTag (PET) using mouse ESCs [14, 15]. For the
analysis, we defined direct targets as those regulated by OCT4
alone or in combination with NANOG and/or SOX2. We found
poor overlap between the three data sets, with 60 genes common
to our data set and that of Boyer et al. [14], 49 common to ours
and the mouse data set [15], and nine common to all three data
sets (supplemental online Fig. 3). Included in the nine genes are
OCT4, NANOG, and SOX2 and the trophoblast inducer EOMES.
Interestingly, CDX2 was a conserved target in human [14] and
not mouse [15].
The list of direct targets of OCT4 in ESCs is given in
supplemental online Table 6. An additional 162 are bound by
NANOG and/or SOX2 but not by OCT4, indicating that these
are regulated indirectly by OCT4 through its regulation of these
downstream effectors (supplemental online Table 7).
In line with the finding that OCT4 regulates its own expres-
sion and that of other core hES transcription factors [14, 28, 29],
it was not surprising that the subset of directly downregulated
genes included NANOG, OCT4, SOX2, HMGB2, and NR2F2
(supplemental online Table 6). Interestingly, the promoters for
HMGB2, a coactivator of OCT4 activity, and NR2F2, a regu-
lator of OCT4 expression [30, 31], are positively and negatively
regulated, respectively, by OCT4 alone. Additional markers of
undifferentiated stem cells identified as positively regulated
direct targets were LEFTY2, DPPA4, and TDGF1, whereas
ZFP42, LEFTY1, and FLJ10884 were classified as indirect
targets. As anticipated, components of signal transduction path-
Figure 3. Confirmation of gene expression
changes of selected genes by real-time PCR
(A) and Western blotting (B). (A): SYBR
green real-time reverse transcription-PCRs
were carried out on RNA samples harvested
72 hours after OCT4 knockdown using two
independent siRNA molecules in separate
transfection experiments (designated siRNA
1 and siRNA 2). Error bars refer to technical
variation. Ratios are represented as log ratio
(base 2), with values above 0 denoting over-
expression and values below 0 denoting re-
pression of gene expression. (B): Western
blots using duplicate samples of protein ex-
tract of the same set of transfection experi-
ments. The specificities of the primary anti-
bodies used are indicated on the left.
Abbreviations: EGFP, enhanced green fluo-
rescent protein; PCR, polymerase chain re-
action; siRNA, small interfering RNA.
















ways implicated in the maintenance of pluripotency, such as
WNT (DKK1, FZD2), TGF (NODAL, LEFTY1, LEFTY2,
MADH3 ID2 and PITX2), FGF (FGF8 and FGF2), and Hedge-
hog (PTCH), are regulated by OCT4.
The remaining genes that are either up- or downregulated
upon OCT4 knockdown but do not appear in the data sets of
Boyer et al. [14] and Loh [15] may represent either previously
undiscovered novel OCT4/SOX2/NANOG targets or genes reg-
ulated by downstream targets of OCT4 other than SOX2 and
NANOG or simply not included in the promoter analysis (sup-
plemental online Table 4). Moreover, this set of genes would
also be expected to include a large number of genes involved in
trophoblast differentiation.
Signaling and Metabolic Pathways Crucial for the
Maintenance of Pluripotency
ESC self-renewal and pluripotency requires inputs from extrin-
sic factors and their downstream effectors [32]. We therefore
analyzed the 24- and 72-hour data set for components of sig-
naling pathways by assigning p values using Wilcoxon’s
matched pair signed rank test to compare groups of genes
associated with particular pathways instead of conventional
gene-wise analysis [20]. The analysis, summarized in Table 1,
identifies changes in key components of the WNT, transforming
growth factor (TGF), fibroblast growth factor (EGF), mitogen-
activated protein kinase, NOTCH, Hedgehog, JAK/STAT, and
extracellular matrix signaling pathways, as well as regulators of
the cytoskeleton, apoptosis, cell cycle, and metabolic processes,
such as oxidative phosphorylation, methionine metabolism, and
folate biosynthesis. The list of complete KEGG annotated path-
ways identified as operative in ESCs is given in supplemental
online Table 8.
TGF and BMP Signaling
Consistent with recent reports identifying TGF/ACTIVIN/
NODAL signaling as critical for maintaining hESC pluripotency
[33–35], expression of NODAL ligand, its coreceptor TDGF1,
and the antagonists LEFTY1 and LEFTY2 is reduced following
OCT4 knockdown (Fig. 4C). Downregulation of LEFTY1,
LEFTY2, and NODAL could result from them being SOX2/
NANOG targets (supplemental online Tables 6 and 7) or
through loss of autocrine NODAL signaling as hESCs differen-
tiate [36]. In contrast, expression of FST (FOLLISTATIN), a
potent ACTIVIN and weak BMP antagonist is significantly
upregulated on OCT4 knockdown (Fig. 4B). Since FST tran-
scription can be induced by ACTIVIN A, this might point to
increased ACTIVIN signaling triggered by OCT4 depletion,
coincident with downregulation of the ACTIVIN A antagonist
TDGF1. OCT4 knockdown increases expression of BMP4 and
its downstream target gene ID2, as well as reducing its antag-
onist CHORDIN (Fig. 4A), in line with the observation that
BMP4 induces trophoblast differentiation in hESCs [17].
FGF Signaling
FGF signaling is known to play an essential role in preventing
hESC differentiation [35, 37, 38], and reduced expression of the
Table 1. Pathways of which gene components show significant expression changes between the OCT4 and EGFP knockdowns at 72 hours after
transfection
KEGGID Pathway description Genesa Z scoreb p valuec OCT4-RNAi-UPd EGFP-RNAi-UPe
hsa04610 Complement and coagulation cascades 25 2.973214 0.001473563 18 7
hsa00230 Purine metabolism 58 2.914994 0.001778544 22 36
hsa04510 Focal adhesion 64 2.708439 0.003380077 43 21
hsa04810 Regulation of actin cytoskeleton 69 2.6696 0.003797128 45 24
hsa04080 Neuroactive ligand-receptor interaction 49 2.660901 0.003896637 30 19
hsa03050 Proteasome 18 2.591246 0.004781487 4 14
hsa00190 Oxidative phosphorylation 58 2.582073 0.004910471 23 35
hsa04010 MAPK signaling pathway 92 2.476518 0.006633556 55 37
hsa04512 ECM-receptor interaction 27 2.25835 0.011961886 18 9
hsa00590 Prostaglandin and leukotriene metabolism 8 2.240448 0.012530885 7 1
hsa04520 Adherens junction 27 2.234325 0.012730806 19 8
hsa00251 Glutamate metabolism 16 2.171768 0.01493653 4 12
hsa00252 Alanine and aspartate metabolism 7 2.02837 0.021261181 1 6
hsa05110 Cholera: infection 13 1.991741 0.023199671 9 4
hsa00710 Carbon fixation 8 1.820364 0.034351738 2 6
hsa00400 Phenylalanine, tyrosine, and tryptophan biosynthesis 5 1.75292 0.039807826 1 4
hsa04630 Jak-STAT signaling pathway 40 1.693603 0.045170345 26 14
hsa00970 Aminoacyl-tRNA biosynthesis 9 1.599342 0.054872314 2 7
hsa04310 Wnt signaling pathway 52 1.575497 0.05757089 31 21
hsa04350 TGF- signaling pathway 28 1.525685 0.063544186 18 10
hsa00440 Aminophosphonate metabolism 7 1.521278 0.064095066 2 5
hsa00052 Galactose metabolism 10 1.477977 0.069707001 8 2
hsa00260 Glycine, serine, and threonine metabolism 17 1.443812 0.074395975 5 12
hsa04110 Cell cycle 45 1.439163 0.075052216 21 24
hsa00640 Propanoate metabolism 15 1.306312 0.095723304 9 6
hsa04210 Apoptosis 30 1.30609 0.095761041 18 12
Pathways were taken from the KEGG database. Gene expression was compared in the OCT4 RNAi and EGFP RNAi at 72 hours, and the
differences of array signals were used for computing Wilcoxon’s paired signed rank test. Genes that were judged as nondetectable by the
background value criterion were excluded from analysis. Shown are pathways with gene numbers 4, but it should be noted that the normal
approximation is valid for sample sizes 25. The complete list of the pathway results is given in supplemental online Table 8.
a Number of genes that were taken into account for computing the statistical test.
b Standard normal approximation of the test statistic.
c p value of the standard normal distribution for the respective Z score.
d Number of genes that have higher expression in OCT4 knockdown than in EGFP knockdown.
e Number of genes that have higher expression in the EGFP knockdown than in the OCT4 knockdown.
Abbreviations: ECM, extracellular matrix; EGFP, enhanced green fluorescent protein; KEGGID, KEGG pathway identifier (Homo sapiens);
MAPK, mitogen-activated protein kinase; RNAi, RNA interference.

















hESC autocrine factor FGF2 and FGF12 was observed on
OCT4 knockdown (Figs. 3, 5A). In contrast, however, expres-
sion of FGF8 and the novel FGF-like receptor FGFRL1 was
upregulated, indicating that hESC differentiation along the tro-
phoblast lineage may involve complex modulation of FGF sig-
naling. It may be significant that a potential NANOG binding
site is identifiable within the FGF8 promoter (supplemental
online Table 7).
Figure 4. Comparative expression patterns of genes involved in the transforming growth factor- signaling pathway. The BMP and ACTIVIN/
NODAL axes of the pathway are presented in (A) and (B, C), respectively. A sequential illustration of the pathways (adapted from the KEGG
database) is given above each histogram. Genes within open boxes are those with background tags 0.9, and therefore their expression was deemed
as not detected. Abbreviation: BMP, bone morphogenetic protein.

















The role of WNT signaling in human ESCs is controversial
because of conflicting reports as to its role in ESC self-renewal
[39, 40]. Our analysis of this pathway shows that although
expression of WNT antagonists DKK1, DKK3, and FRZB in-
creases upon OCT4 knockdown, FRAT2, a GSK3-interacting
positive effector of WNT signaling [41], is downregulated (Fig.
5C). The presence of OCT4, NANOG, and SOX2 binding sites
within the DKK1, FZD2, and FRAT2 promoters indicates that
these WNT components are influenced directly by these key
stem cell regulators (supplemental online Table 6).
NOTCH and Hedgehog Signaling
Although both these pathways regulate the fate of many types of
stem cells, there is currently little evidence for their involvement
in controlling the fate of embryonic stem cells [42]. Examina-
tion of NOTCH pathway components revealed downregulation
of CBF2 and upregulation of NOTCH2, TLE2, DTX4, and HES1
upon OCT4 knockdown (Fig. 5D). TLE2, a transcriptional re-
pressor [43], is regulated by NANOG and SOX2 (supplemental
online Tables 6 and 7). Analysis of Hedgehog (Hh) signaling
components showed reduced levels of both PTCH1, a Hh re-
ceptor and target for SOX2 and NANOG (supplemental online
Table 7), and the Hh-regulated transcriptional repressor GLI3.
Apoptosis
Efficient growth of undifferentiated ESCs (self-renewal) re-
quires the inhibition of apoptosis, as well as differentiation [44];
we therefore screened the data set for differentially expressed
apoptosis-related genes (Fig. 5B). Although expression levels of
the pro- and antiapoptotic genes BCL2 and BAX did not change,
genes encoding the DNA fragmentation factor (DFFA), the
apoptosis-inducing factor (PDCD8), and CASPASE 3 were sig-
nificantly downregulated, whereas NFKBIA and the calpains
CAPN6, CAPN1, and CAPNS1 were upregulated on OCT4
knockdown.
Epigenetic Control of Pluripotency and Trophoblast
Lineage Specification
Mutant mouse ESCs lacking DNA methyltransferase activity
[45, 46], methyl DNA binding protein function [47], or histone
acetylase activity [48] exhibit impaired differentiation, high-
lighting the critical role chromatin modification plays in regu-
lating embryonic differentiation. To investigate whether the
expression of chromatin and epigenetic modifiers is affected by
OCT4 depletion, we identified differentially regulated genes
involved in methyl/folate cycle, DNA methylation, methyl DNA
binding, and histone modification communication (supplemen-
tal online Fig. 4). Downregulation of MAT2A (methionine ad-
enosyltransferase II ) and MTRR (5-methyltetrahydrofolate-
homocysteine methyltransferase) was observed at 72 hours of
OCT4 depletion (supplemental online Fig. 4A), supporting the
involvement of folic acid metabolism in the maintenance of
pluripotency [49]. The de novo methyltransferase DNMT3B was
downregulated upon OCT4 depletion, contrasting with the
maintenance methylase DNMT1, which showed no significant
change. The, histone lysine methyltransferase (H3-K4-HMTase)
SET7 was dramatically upregulated upon OCT4 knockdown,
contrasting with downregulation of the histone lysine methyl-
transferase EZH2 (H3-K27-HMTase) (supplemental online Fig.
4B). The acetylases H2AFY and H2AFY2 and the deacetylase
HDAC6 also show significant upregulation on OCT4 knock-
down (supplemental online Fig. 4C, 4D). These expression
patterns perhaps indicate that the hES-to-trophoblast transition
is accompanied by significant changes in histone acetylation and
methylation patterns.
The nonhistone chromatin-associated proteins HMGB1,
HMGB3, DPPA4, NASP, chromatin assembly factor 1
(CHAF1A), PHF17, PHF5A, POLE3, and retinoblastoma bind-
ing protein 7 (RBBP7) are all significantly downregulated as a
consequence of OCT4 depletion (supplemental online Fig. 4B).
Of these, HMGB1, DPPA4, and HMGB3 have previously been
shown to be highly enriched in undifferentiated stem cells and
Figure 5. Comparative expression patterns of genes involved in FGF (A), apoptosis (B), WNT (C), and NOTCH (D) signaling pathways.
Abbreviations: FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor.

















isolated ICM cells [20]. The RBBP7-encoded protein has been
shown to interact with MBD3 and may have a role in the
regulation of cell proliferation and differentiation [50].
Interestingly, we also observed downregulated expression of
PARP1 (Fig. 3), which encodes a chromatin-associated enzyme,
poly(ADP-ribosyl) transferase, capable of modifying nuclear
proteins. This DNA-dependent ribosylation has been shown to
regulate cell proliferation, transformation, and differentiation
[51]. Indeed, Parp1-deficient mouse embryonic stem cells dif-
ferentiate more readily into trophoblast-like cells, implying that
one of the functions of this protein is to restrict differentiation in
this lineage [52].
Altered expression of imprinted genes was also observed
(upregulation of CALCR and GNAS and downregulation of
KIP2 and UBE3A; supplemental online Fig. 4E). KIP2 (a cyclin-
dependent kinase inhibitor) acts as a key regulator of embryo-
genesis through regulation of cell cycle by blocking the activity
of G1 cyclin/Cdk complexes and the regulation of actin dynam-
ics through binding to LIMK-1 [53, 54]. Differential gene
expression of other cell cycle-related genes was also observed
(supplemental online Fig. 5), including the upregulation of
CDKN2B, a cyclin-dependent kinase inhibitor, and downregu-
lation of CDC25A, which is required for progression from G1 to
the S-phase of the cell cycle, consistent with the limited G1
phase and rapid cell cycle characteristic of undifferentiated
ESCs [55, 56].
RNAi-Mediated Suppression of OCT4 Function in
Human ESCs Recapitulates Primary Differentiation
at the Blastocyst Stage of Development
To examine how closely the transcriptomes of an ICM and
trophectoderm (TE) cell matches that of an undifferentiated
ESC and OCT4 RNAi-mediated trophoblast cell, we compared
our current data set with that derived from the blastocyst [20].
We identified potential candidate genes that were overexpressed
in the TE- and OCT4-deficient ESCs compared with the ICM
and undifferentiated ESCs when a cluster analysis of genes
coregulated in the same manner as BMP4 was performed (Fig.
6). Genes upregulated in the TE- as well as the OCT4-depleted
hESCs are involved in the organization of the extracellular
matrix (PDLIM3), cell growth and differentiation (AKR1C3 and
PLXND1), transcriptional regulation (PME-1, MGC11349/
ZXDC, and KIAA1245/COAS1), signal transduction processes
(ARL7, PIP5K1C, RASL12, ARHGAP8, SELM, and DKK3, an
inhibitor of the WNT pathway), and novel genes (KIAA1949,
C14orf173, and FLJ20507/TMEM127). We do not present de-
tailed analysis of this data set here for the simple reason that the
vast amount of data is beyond the scope of this study. In
summary, these results would imply that these TE marker genes
could serve as additional factors required for inducing tropho-
blast differentiation and further propagation of these cells.
DISCUSSION
The first differentiation event in mammalian development is the
formation of the trophectoderm; this event is controlled by
antagonism between OCT4 and the trophoblast transcription
factors CDX2 and EOMES [27]. To begin dissecting the com-
plex molecular events that underpin this event in humans, we
adopted a functional genomics approach using RNAi to sup-
press OCT4 function in a human ESC line and microarray-based
gene expression profiling. The quality of the data set was
rigorously tested in several ways, including numerous statistical
tests, achieving consistent reproducibility between replicates as
measured by the coefficient of variations of intensity for each
gene. The data set is therefore qualitative, quantitative, and
comprehensive.
Our microarray analysis shows that OCT4 knockdown in
hESCs is accompanied by a reduction in overall complexity of
gene expression and differential regulation of more than 1,000
genes, many of which are consistent with a loss of pluripotency
and specification of the trophoblast lineage. Among the differ-
entially expressed genes, 60 correspond to direct OCT4 targets
identified in human ESCs [14], 49 to targets in mouse ESCs
[15], and nine (including OCT4, SOX2, NANOG, and EOMES)
to targets identified as conserved in human and mouse ESCs. An
additional set of 162 consists of targets for SOX2 and NANOG,
but not OCT4 [14, 15]. This pattern is compatible with OCT4,
SOX2, and NANOG constituting an interdependent network,
where loss of expression of one factor ultimately leads to the
extinction of the others. A differentiation pathway may depend
on factor-specific interactions (for example, between OCT4,
EOMES, and CDX2 [27]) or other genes. The overall low
overlap may be attributed to the differences in the platforms
used (RNAi, ChIP-chip, and ChIP-PET) and also the transcrip-
tion factor binding sites being mapped. In addition, off-target
indirect effects induced by the OCT4-RNAi manipulation in our
study and that in the mouse [15] may have contributed to the
disparity between our list of OCT4 targets. Nonetheless, we
cannot exclude the possibility of species differences in the mode
of regulation of pluripotency and self-renewal of ESCs. Indeed,
our analysis of changes in gene expression and gene ontologies
highlights the involvement of cell signaling interactions, epige-
netic modifications, chromatin remodeling, and metabolic pro-
cesses in the ES-to-trophoblast transition.
Examination of differentially expressed components of sig-
nal transduction pathways supports previous findings demon-
strating the importance of TGF, BMP, and FGF signaling in
regulating hESC differentiation [18, 35]. NODAL, its coreceptor
TDGF1, and transcriptional targets, LEFTY1/2 were downregu-
lated upon OCT4 knockdown, whereas the ACTIVIN-regulated
antagonist Follistatin was upregulated. This might reflect a
switch from NODAL/TDGF1 to ACTIVIN signaling during
trophoblast differentiation and would be compatible with the
recently reported involvement of ACTIVIN in trophoblast pro-
Figure 6. Cluster analysis of 15 genes bearing expression profiles the
most similar to that of the trophoblast marker BMP4. The comparison
was made between this study and the previously published expression
data on human ICM and trophectoderm cells [20]. Colors correspond to
normalized signals. For each gene, signals were divided by the average
gene signal across all conditions (log scale). Red boxes indicate that the
signal in the particular condition is higher than the average signal,
whereas green boxes indicate the opposite. Hierarchical clustering dis-
plays subgroups using Pearson correlation as a pairwise similarity
measure and complete linkage as an update rule. The analysis was done
using J-Express Pro 2.6 software (MolMine AS). Abbreviations: EGFP,
enhanced green fluorescent protein; ICM, inner cell mass; MAX, max-
imum; MIN, minimum; RNAi, RNA interference.
















liferation in mouse [57, 58]. BMP4, an inducer and marker of
trophoblast, was upregulated upon OCT4 knockdown within 24
hours. Given the importance of this factor in regulating ESCs
from both mouse and human ESCs, it is notable that the BMP4
promoter was not identified as a target of OCT4, nor of SOX2
or NANOG, indicating that the induction could be mediated
indirectly [14]. This could entail a cascade involving GATA6, a
target of OCT4 and NANOG in hESCs and regulator of BMP4
expression [59] or NANOG [60]. FGF2 expression is down-
regulated upon OCT4 knockdown, consistent with FGF signal-
ing blocking hESC differentiation. However, the induction of
FGF8 also points to a likely role for this pathway in trophoblast
differentiation. Indeed, induction of components of NOTCH
signaling upon OCT4 knockdown could mediate aspects of FGF
signaling to promote the generation of trophoblast progenitors
[61], in a manner related to that described for neural differen-
tiation in ESCs and somatic progenitor cells [62, 63]. Many
signaling pathways regulate cell survival, as well as differenti-
ation, and it was therefore interesting to find that some pro-
apoptotic genes, including CASPASE 3, were downregulated on
OCT4 knockdown, supporting the notion that ESCs may be
inherently poised for apoptosis because of conflict between
signals maintaining the balance between self-renewal and dif-
ferentiation [16, 44].
OCT4 downregulation also had significant effects on ex-
pression of epigenetic and chromatin modifiers. The reciprocal
expression patterns of the histone lysine methyltransferases
SET7 (up) and EZH2 (down), as well as downregulation of the
DNA methyltransferase DNMT3B and a number of histone and
nonhistone chromatin-associated proteins, suggest that loss of
pluripotency is associated with global changes in chromatin
organization [64]. These changes may be actively involved in
ESC differentiation per se, but they may, in addition, specifi-
cally reflect the generation of an extraembryonic cell type.
As anticipated, the list of OCT4-dependent genes includes
as yet uncharacterized novel genes that may represent candi-
dates for further investigation into pluripotency and trophoblast
differentiation. Our data provide a reference for combining
RNAi and functional genomics using human ESCs to study
some of the earliest differentiation events of human postimplan-
tation development. This is supported by the finding that the
trophoblast marker BMP4 is enriched in both the TE- and the
OCT4-depleted cells at both the 24- and 72-hour time points.
Furthermore, the global analysis (data not shown) revealed
distinct and overlapping expression patterns between the ICM
and undifferentiated ESCs, thus implying that the ICM consist
of a transit population of pluripotent cells and that cultured
ESCs are an in vitro adaptation of these. Alternatively, the
differences between the two data sets may be explained by
experimental limitations associated with the scarce human em-
bryo material [20]. Detailed analysis and confirmation of these
differences are under way and therefore not included here, as
they are beyond the scope of the current study. This type of
undertaking should also contribute to the construction of a
molecular framework that facilitates robust and predicable con-
trol of ESC differentiation and their successful and safe appli-
cation in stem cell-based therapy in the future.
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